Clinical and Scientific Advisory

Dr Irish is a Clinical Professor at the University of Western Australia and a Clinical Nephrologist and Renal Transplant Lead Clinician at Fiona Stanley Hospital, with expertise in clinical research in dialysis and renal transplantation, chronic kidney disease, cardiovascular disease, renal paraprotein disorders, dyslipidaemias and thrombosis in renal disease and glomerulonephritis. Dr Irish provides inpatient and outpatient services at Fiona Stanley Hospital, St John of God Subiaco Hospital and St John of God Murdoch Hospitals, and visits the Pilbara on a regular basis. He is the Clinical Lead for West Australian Country Health Service (WACHS) Renal Program.

Dr Thin is a Consultant Gastroenterologist at Fiona Stanley Hospital with a special interest in Inflammatory Bowel Disease. Dr Thin is the Principal Investigator for the IBD Research unit at Fiona Stanley Hospital, recruits to multiple international clinical trials and sits on numerous advisory boards. She is an executive member for the Australian New Zealand IBD research consortium and was recently an IBD faculty member for the Gastroenterology Society of Australia. Dr Thin has a keen interest in managing complex IBD patients and improving quality of care for IBD patients. Dr Thin is an Adjunct Senior Clinical Lecturer with the University of Western Australia’s medical school. She has extensive experience with performing intestinal ultrasounds, is a certified intestinal sonographer with IBUS and GENIUS and an accredited trainer with GENIUS.

Dr Musk is a Respiratory Physician and Medical Director at Fiona Stanley Hospital. He serves as Head of Service, Advanced Lung Disease Unit at Fiona Stanley Hospital and specialises in all aspects of general respiratory medicine with special interests in Lung Transplantation, Interstitial Lung Disease, Pulmonary Vascular +61 8 6268 2641 ir@neuroscientific.com Level 4, 216 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000 Disease, Surgical management of Emphysema. Michael has been the Principle Investigator of numerous clinical trials in treatment of Idiopathic Pulmonary Fibrosis, lung transplantation, Bronchiolitis, and Bronchiectasis with a special research interest in understanding the pathogenesis of post lung transplant obliterative bronchiolitis. Dr Musk is a member of the Transplant Society of Australia and New Zealand, previous Chair of Lung Transplant Advisory Committee of the Thoracic Society of Australia and New Zealand and member of International Society of Heart and Lung Transplantation.

Prof Moodley is a Consultant Respiratory Physician at Fiona Stanley Hospital, Professor of Respiratory Medicine at the University of Western Australia, and the Co-Deputy Director and Research Leader of the Cell Biology Group at the Institute for Respiratory Health. He is also a chief investigator in the Centre for Research Excellence in Pulmonary Fibrosis and serves on the scientific advisory board of Roche and Boehringer Ingelheim, as well as the steering committee for the Interstitial Lung Disease registry in Australia. Prof Moodley’s areas of expertise include pulmonary fibrosis, chronic obstructive pulmonary disease (COPD) and cell biology of the lung. His research interests include finding biomarkers the diagnosis and monitoring of lung conditions such as Idiopathic Pulmonary Fibrosis (IPF) and finding novel therapies for COPD and pulmonary fibrosis, with further focus on the epigenetic and molecular pathogenesis of IPF.